Principal Investigator
David Baidal
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20251079
Clinical Trial Summary
POLARIS: A PHASE 1, SINGLE DOSE, OPEN-LABEL STUDY OF
GNTI-122 IN ADULTS WITH RECENTLY DIAGNOSED TYPE 1
DIABETES (T1D)
Phase
TBD
Funding Agency/Sponsor
Industry
Disease
Other
Contact Information
Study Contact
Burlett Masters
Phone Number
+1 (305) 2435354
Email
bmasters2@miami.edu